These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8955881)

  • 21. Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues.
    Taylor JW; Jin QK; Sbacchi M; Wang L; Belfiore P; Garnier M; Kazantzis A; Kapurniotu A; Zaratin PF; Scheideler MA
    J Med Chem; 2002 Feb; 45(5):1108-21. PubMed ID: 11855991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Goldfish calcitonin: purification, characterization, and hypocalcemic potency.
    Sasayama Y; Ukawa K; Kai-Ya H; Oguro C; Takei Y; Watanabe TX; Nakajima K; Sakakibara S
    Gen Comp Endocrinol; 1993 Feb; 89(2):189-94. PubMed ID: 8454163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of glycosylation on the structure and dynamics of eel calcitonin in micelles and lipid bilayers determined by nuclear magnetic resonance spectroscopy.
    Hashimoto Y; Toma K; Nishikido J; Yamamoto K; Haneda K; Inazu T; Valentine KG; Opella SJ
    Biochemistry; 1999 Jun; 38(26):8377-84. PubMed ID: 10387083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
    Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
    Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of (Asu1,7)E-CT, synthetic analogue of eel-calcitonin, on nociceptive transmission.
    Clementi G; Amico-Roxas M; Caruso A; Fiore CE; Trombadore S; Scapagnini U
    Pharmacol Res Commun; 1985 Oct; 17(10):967-73. PubMed ID: 2999838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various protease inhibitors in rats.
    Morita T; Yamamoto A; Takakura Y; Hashida M; Sezaki H
    Pharm Res; 1994 Jun; 11(6):909-13. PubMed ID: 7937534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressive effect of elcatonin, an eel calcitonin analogue, on excessive urinary hydroxyproline excretion in polyostotic fibrous dysplasia (McCune-Albright's syndrome).
    Yamamoto K; Maeyama I; Kishimoto H; Morio Y; Harada Y; Ishitobi K; Ishikawa J
    Endocrinol Jpn; 1983 Oct; 30(5):651-6. PubMed ID: 6423374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypocalcemic actions of amylin amide in humans.
    Wimalawansa SJ; Gunasekera RD; Datta HK
    J Bone Miner Res; 1992 Sep; 7(9):1113-6. PubMed ID: 1414504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of eel-calcitonin and (asu1,7)-eel-calcitonin: contribution of the disulfide bond to the hormonal activity.
    Morikawa T; Munekata E; Sakakibara S; Noda T; Otani M
    Experientia; 1976 Sep; 32(9):1104-6. PubMed ID: 971732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure/activity relationship of eel calcitonin. A study using a newly devised method for designing analogs.
    Inoue A; Shikano M; Komatsu Y; Obata J; Ochiai J; Nishide H; Ito N; Nagao H; Kondo K; Tunemoto D
    Eur J Biochem; 1991 Nov; 201(3):607-14. PubMed ID: 1657602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of non-ionic surfactants in a polyacrylic acid gel base on the rectal absorption of [Asu1,7]-eel calcitonin in rats.
    Morimoto K; Akatsuchi H; Morisaka K; Kamada A
    J Pharm Pharmacol; 1985 Oct; 37(10):759-60. PubMed ID: 2867154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analogues of human calcitonin. II. Influence of modifications in amino acid positions 1, 8 and 22 on hypocalcemic activity in the rat.
    Maier R; Kamber B; Riniker B; Rittel W
    Horm Metab Res; 1975 Nov; 7(6):511-4. PubMed ID: 1213659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of alendronate on plasma calcium levels, urinary calcium excretion, and bone resorption markers in normal rats: comparison with elcatonin, synthetic eel calcitonin.
    Azuma Y; Chokki M; Ohta T; Kiyoki M
    Endocrinology; 1996 Jun; 137(6):2586-92. PubMed ID: 8641213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of restraint stress by systemic (Asu1,7) eel-calcitonin.
    Clementi G; Prato A; Rapisarda E; Conforto G; Mangano O; Caruso A; Scapagnini U
    J Endocrinol Invest; 1985 Dec; 8(6):543-6. PubMed ID: 3833898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcitonin of the stingray: comparison of the hypocalcemic activity with other calcitonins.
    Sasayama Y; Suzuki N; Oguro C; Takei Y; Takahashi A; Watanabe TX; Nakajima K; Sakakibara S
    Gen Comp Endocrinol; 1992 May; 86(2):269-74. PubMed ID: 1601276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression by intravenous injection of [Asu(1),(7)]-Eel calcitonin of suckling-induced prolactin release in rats.
    Chihara K; Iwasaki J; Minamitani N; Kobayashi Y; Fujita T
    Horm Metab Res; 1981 Sep; 13(9):535-6. PubMed ID: 7298025
    [No Abstract]   [Full Text] [Related]  

  • 37. Eel calcitonin suppresses plasma human calcitonin levels in medullary carcinoma of the thyroid.
    Morimoto S; Miyauchi A; Fukuo K; Imanaka S; Yamamoto H; Tsuchiya H; Koh E; Yukawa S; Onishi T; Avioli LV
    Clin Sci (Lond); 1986 Apr; 70(4):333-8. PubMed ID: 3698510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcitonin.
    Sexton PM; Findlay DM; Martin TJ
    Curr Med Chem; 1999 Nov; 6(11):1067-93. PubMed ID: 10519914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bimodal action of [Asu1,7]eel-calcitonin on phosphoinositide hydrolysis in cultured anterior pituitary cells.
    Sortino MA; Canonico PL; Clementi G
    Eur J Pharmacol; 1991 Aug; 207(4):345-50. PubMed ID: 1664337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in serum calcium concentration following eel calcitonin analogue administration as an index of osteoclastic bone resorption in patients with secondary hyperparathyroidism].
    Kato N
    Nihon Jinzo Gakkai Shi; 1995 May; 37(5):291-9. PubMed ID: 7609328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.